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Abstract
Reliable and rapid diagnosis of inﬂuenza A H1N1 is essential to
initiate appropriate antiviral therapy and preventive measures. We
analysed the differences in clinical presentation and laboratory
parameters between emergency department patients with
PCR-conﬁrmed H1N1 inﬂuenza infection (n = 199) and those
with PCR-negative inﬂuenza-like illness (ILI; n = 252). Cough,
wheezing, leucopenia, eosinopenia and a lower C-reactive protein
remained signiﬁcant predictors of H1N1 inﬂuenza. Proposed
combinations of clinical symptoms with simple laboratory param-
eters (e.g. reported or measured fever and either cough or
leucocytes <8.5 9 109/L) were clearly superior to currently used
ofﬁcial ILI case deﬁnitions that use clinical criteria alone.
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During the inﬂuenza pandemic of 2009–2010 the vast majority
of inﬂuenza-associated diseases were caused by the subtype
H1N1 [1,2]. In clinical practice the decision regarding whether
to initiate preventive and therapeutic measures mostly depends
on recommended case deﬁnitions for inﬂuenza-like illness (ILI),
which rely exclusively on clinical signs and symptoms, or on
speciﬁc laboratory tests. Published data on the diagnostic
strength of clinical case deﬁnitions, however, are inconsistent
[3–5]. In emergency departments the limitations of clinical case
deﬁnitions cannot be compensated for by available speciﬁc
laboratory tests. The highly sensitive and speciﬁc polymerase
chain reaction (PCR) is cost-intensive and results are usually
not available in time for therapeutic or preventive decisions [6].
The rapid inﬂuenza antigen immunoassays have an unsatisfying
pooled overall sensitivity of 62.3%, which has been even lower
during the H1N1 pandemic (56.3%) [7].
The study (a case-negative control series) was conducted
at the Medical University Hospital of Graz, Austria, and
comprised emergency department patients tested by PCR for
the presence of pandemic (H1N1) 2009 inﬂuenza infection by
the two reference laboratories of Styria, south-east Austria.
Being the only laboratories in the area performing inﬂuenza
PCR for practitioners and hospitals, they serve 1.5 million
people. Case ﬁles of patients investigated for inﬂuenza and
tested with the IVD/CE-labeled artus Inﬂuenza/H1 LC
RT-PCR Kit (Qiagen, Hilden, Germany) between October
2009 and January 2010 (i.e. the surveillance period of the
pandemic H1N1 inﬂuenza) were retrospectively evaluated.
During the study period inﬂuenza RT-PCR (from nasal and
throat viral swabs obtained by trained staff) was performed in
1669 patients with clinical suspicion of inﬂuenza. Due to the
pandemic situation, samples were tested only for inﬂuenza
and not for other respiratory viruses. Inﬂuenza PCR was
positive in 624 patients (all inﬂuenza A H1N1, no seasonal
inﬂuenza strain detected) and negative in 1045 patients; all
patients were screened for study inclusion. Patients were
included in the study when datasets (laboratory and clinical)
were available from ‘Medocs LKH Steiermark’, the electronic
Styrian Hospital Network comprising all Styrian Public
Hospitals (n = 15) with emergency units (n = 560 patients).
We excluded 56 patients with delayed PCR testing (tested
>7 days after the onset of the recent disease), 48 severely
immunocompromised/neutropenic patients, and ﬁve healthy
and completely asymptomatic patients. Finally, 199/624 (32%)
patients with PCR-conﬁrmed H1N1 infection and 252/1045
(24%) with PCR-negative ILI were included in the analysis. Data
were collected systematically in both groups by reviewing the
patients’ medical records. In a second step we developed a
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simple case deﬁnition including clinical and laboratory param-
eters and compared performance with ofﬁcial case deﬁnitions.
All statistical analyses were performed using the Statistical
Package for Social Sciences version 20.0 (SPSS Inc., Chicago, IL,
USA) and SAS 9.2 (SAS Institute Inc., Cary, NC, USA).
Explanatory variables with p < 0.20 in univariate logistic
regression analysis were included in the multivariable logistic
models. For ﬁnal variable selection, bootstrap resampling was
used [8]. Goodness of ﬁt was evaluated with the Hos-
mer-Lemeshow test and the c-index. Potential explanatory
variables were checked for collinearity prior to inclusion in the
regression models. The study protocol has been approved by
the local ethics committee, Medical University Graz, Austria
(EC-number 23-049 ex 10/11).
Patients with H1N1 were signiﬁcantly younger (median 16
years, range 0–79) than those with inﬂuenza PCR-negative ILI
(median 24 years, range 0–92), while the sex distribution did
not differ signiﬁcantly (data not shown). Differences in clinical
data and laboratory parameters determined at admission to
the emergency room (ER) were analysed using univariate and
multivariable analysis (Table 1). The performance of ofﬁcial
case deﬁnitions that rely exclusively on clinical signs and
symptoms and that of simpliﬁed and modiﬁed case deﬁnitions
that also include laboratory admission parameters are depicted
in Table 2.
Current ILI case deﬁnitions integrate exclusively clinical
criteria such as sudden onset of disease and systemic and
respiratory symptoms. However, bacteria and other respira-
tory viruses that circulate at the same time as inﬂuenza can
cause similar disease. Further, many cases of acute inﬂuenza
infection are less symptomatic and do not fulﬁll the classic ILI
case deﬁnitions. ILI symptoms for diagnosis of inﬂuenza are
therefore neither sensitive nor speciﬁc [9–11].
Also, the inaccuracy of speciﬁc H1N1 clinical case deﬁni-
tions still poses a problem. In an interesting approach Mahony
and colleagues attempted to improve case deﬁnitions of the
pandemic by using a scoring system based on multiple clinical
ﬁndings at presentation but failed to improve these deﬁnitions
signiﬁcantly [12]. In our study collective, modiﬁed clinical case
deﬁnitions without the criterion of sudden onset but with
inclusion of just one laboratory parameter (leukocyte count of
<8.5 9 109/L) improved the sensitivity and the NPV remark-
ably. The additional use of CRP with a cut-off of <50 mg/L or
eosinopenia (data not shown) did not lead to a further
improvement of the deﬁnitions.
Consequently, we regard leukopenia or the absence of
leukocytosis as a potential additional criterion for ILI case
deﬁnitions. Although leukocyte count is a weak parameter for
differentiation between bacterial and viral respiratory diseases
in general [13], it might be useful to differentiate inﬂuenza
infections from both non-inﬂuenza respiratory virus infections
and bacterial respiratory tract infections [14–16]. A study
showing a signiﬁcant lower leukocyte count in H1N1 infections
than in other respiratory virus infections supports this
assumption [10]. Based on another study that found high
rates of patients with normal to low WBC in both H1N1 and
H3N2-infected patients, it should be considered that the value
of normal or low WBC for differentiation between non-inﬂu-
enza ILI and inﬂuenza infection might not be restricted to
H1N1 only [17].
TABLE 1. Comparison of clinical data and laboratory admission parameters between patients with H1N1 and patients with
PCR-negative inﬂuenza-like illness. Result of univariate and multivariable analysisa
Parameter
Univariate analysis Multivariable analysis
OR 95% CI p-value OR 95% CI p-value
Age (year) 0.986 0.978–0.994 0.001 n.s.
Reported or measured fever <0.001 n.s.
Yes 3.863 2.081–7.168
No Ref.
Cough <0.001 <0.001
Yes 2.669 1.789–3.980 3.039 1.867–4.947
No Ref. Ref.
Wheezing 0.003 0.012
Yes 2.784 1.423–5.445 2.712 1.246–5.903
No Ref. Ref.
Rhinitis 0.016 n.s.
Yes 1.790 1.115–2.875
No Ref.
Absolute eosinophil count (9109/L) 0.837 0.703 –0.997 0.046 0.678 0.548–0.840 <0.001
WBC (9109/L) 0.864 0.822–0.908 <0.001 0.890 0.840–0.943 <0.001
Thrombocytes (9109/L) 0.997 0.995–0.999 0.006 n.s.
Monocytes (%) 1.090 1.038–1.144 0.001 n.s.
C-reactive protein (mg/L) 0.991 0.987–0.994 <0.001 0.991 0.988–0.995 <0.001
Creatinkinase (U/L) 1.001 1.000–1.002 0.034 n.s.
Haemoglobin (mg/L) 1.072 0.973–1.180 0.161 n.s.
CI, conﬁdence interval; n.s., not signiﬁcant; OR, odds ratio; WBC, white blood count.
aVariables that were signiﬁcant predictors in more than 60% of the bootstrap samples were included (c-index 0.78; p-value Hosmer-Lemeshow goodness of ﬁt test 0.0928).
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Using the modiﬁed case deﬁnitions that combine clinical
ﬁndings and WBC in emergency departments may lead to (i) a
signiﬁcantly higher number of inﬂuenza-suspects being identi-
ﬁed within the important initial 48-h window, (ii) more
discharged patients getting recommendations for home quar-
antine, (iii) more high-risk patients receiving antiviral treatment
and (iv) more hospitalized patients being put on preventive
measures to avoid nosocomial spread of infection. However,
as speciﬁcity and PPV of all case deﬁnitions are low, respiratory
specimens should be obtained from positively screened
hospitalized patients for molecular testing.
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